Corteva, Inc. (NYSE:CTVA) Receives $84.76 Consensus Price Target from Brokerages

Shares of Corteva, Inc. (NYSE:CTVA) have been assigned an average recommendation of “Moderate Buy” from the twenty-three ratings firms that are covering the firm, Marketbeat Ratings reports. Nine analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. The average 1-year price target among analysts that have issued a report on the stock in the last year is $85.1905.

Several brokerages have commented on CTVA. Zacks Research lowered shares of Corteva from a “strong-buy” rating to a “hold” rating in a research report on Friday, February 20th. Jefferies Financial Group boosted their target price on shares of Corteva from $85.00 to $95.00 and gave the stock a “buy” rating in a research report on Monday, March 2nd. UBS Group boosted their target price on shares of Corteva from $80.00 to $88.00 and gave the stock a “neutral” rating in a research report on Thursday, April 9th. Wolfe Research boosted their target price on shares of Corteva from $81.00 to $86.00 and gave the stock an “outperform” rating in a research report on Thursday, February 5th. Finally, The Goldman Sachs Group boosted their price objective on shares of Corteva from $88.00 to $96.00 and gave the stock a “buy” rating in a research report on Tuesday, April 14th.

Corteva Stock Performance

Shares of CTVA opened at $79.78 on Wednesday. The company has a current ratio of 1.43, a quick ratio of 0.96 and a debt-to-equity ratio of 0.07. The firm has a market cap of $53.56 billion, a PE ratio of 50.50, a price-to-earnings-growth ratio of 2.73 and a beta of 0.68. The company’s 50 day simple moving average is $80.09 and its 200-day simple moving average is $71.60. Corteva has a 12-month low of $60.53 and a 12-month high of $85.63.

Corteva (NYSE:CTVA) last posted its quarterly earnings data on Tuesday, February 3rd. The company reported $0.22 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.22. Corteva had a net margin of 6.29% and a return on equity of 9.06%. The firm had revenue of $3.91 billion for the quarter, compared to analyst estimates of $4.23 billion. During the same period last year, the firm posted $0.32 EPS. Corteva’s quarterly revenue was down 1.7% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, equities analysts predict that Corteva will post 3.62 EPS for the current year.

Corteva Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, March 16th. Investors of record on Monday, March 2nd were given a $0.18 dividend. The ex-dividend date was Monday, March 2nd. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. Corteva’s payout ratio is currently 45.57%.

Insiders Place Their Bets

In related news, insider Brian Titus sold 8,311 shares of the business’s stock in a transaction dated Friday, February 20th. The shares were sold at an average price of $76.55, for a total value of $636,207.05. Following the completion of the transaction, the insider owned 8,090 shares of the company’s stock, valued at approximately $619,289.50. The trade was a 50.67% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 0.15% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Root Financial Partners LLC increased its stake in shares of Corteva by 11.7% during the 1st quarter. Root Financial Partners LLC now owns 2,174 shares of the company’s stock valued at $182,000 after acquiring an additional 228 shares during the last quarter. CHICAGO TRUST Co NA increased its stake in shares of Corteva by 88.5% during the 1st quarter. CHICAGO TRUST Co NA now owns 7,446 shares of the company’s stock valued at $623,000 after acquiring an additional 3,496 shares during the last quarter. Financial Life Planners acquired a new position in shares of Corteva during the 1st quarter valued at about $55,000. Bayban increased its stake in shares of Corteva by 113.7% during the 1st quarter. Bayban now owns 500 shares of the company’s stock valued at $42,000 after acquiring an additional 266 shares during the last quarter. Finally, Premier Path Wealth Partners LLC increased its position in Corteva by 54.0% during the 1st quarter. Premier Path Wealth Partners LLC now owns 18,487 shares of the company’s stock worth $1,548,000 after purchasing an additional 6,482 shares in the last quarter. Institutional investors and hedge funds own 81.54% of the company’s stock.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.